Public trial registry of the CCC-Munich

Trial CINC424B2301 (RESPONSE)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CINC424B2301 (RESPONSE)
World
Full title
:

Randomized, open label, multicenter phase III study of Efficacy and Safety in Polycythemia vera subjects who are resistant to or intolerant of hydroxyurea: JAK inhibitor INC424 Tablets versus best available care (The RESPONSE Trial)

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 M√ľnchen Germany Tum
Indications
Classification Code Description
- D45 Polycythaemia vera
- - Polycythemia vera -
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Sonstige,Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Philipp Jost Keine Organisationseinheit angegeben Magnifier